Want to join the conversation?
$FITB's expenses were $943MM vs. $947MM in 2Q15 reflecting $9MM higher compensation expense primarily related to executive retirements and severance, partially offset by reversal of litigation reserves. Excluding student loan backed commercial credit, net charge-offs were $86MM or 37 BP which was flat with 2Q15 net charge-offs.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?